Michael H. Carrel, President, CEO, & Director at AtriCure, Inc. (ATRC), sold 175,498 shares at $51.00 ($9.2M) on 2020-12-17, disclosed to the SEC on 2020-12-21.
Open-market sale of $9.2M ATRC by President, CEO, & Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.00 | 25,000 | $1.3M | 13.6% |
| 2 | $51.00 | 25,000 | $1.3M | 13.9% |
| 3 | $52.00 | 25,000 | $1.3M | 14.1% |
| 4 | $53.51 | 50,249 | $2.7M | 29.2% |
| 5 | $53.51 | 50,249 | $2.7M | 29.2% |
| Total | $52.44 avg | 175,498 |
| $9.2M |
| 100% |
| Filing → |
| ATRC | SELL | 2021-02-04 | $1.5M | — | Filing → |
| ATRC | SELL | 2021-01-13 | $1.5M | — | Filing → |
| ATRC | SELL | 2020-12-28 | $1.4M | — | Filing → |